Recommended across the site

Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.
We explain how to assess liver function including the purpose of liver blood tests, how to interpret them and what to do if they are abnormal.
Norethisterone is the licensed choice for delaying menstruation, but it is not always the most appropriate choice.
An overview of possible dose equivalences, switching methods and considerations to make before switching between gabapentinoids in adults with neuropathic pain.
The availability of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD) varies currently. Supply content is maintained regularly by DHSC.

Recommended in PGDs

Delegation of any PGD function is not permitted. However there are specific tasks that individuals other than the professional working under a PGD can fulfil.
Understand what a Patient Group Direction (PGD) is and how it is used in clinical practice.
Understanding when PGDs are a suitable mechanism for the supply and/or administration of medicines ensures an appropriate legal framework for service provision.
Understanding when PGDs are an unsuitable mechanism for the supply and/or administration of medicines ensures an alternative legal framework is applied.
Understanding where PGDs can and cannot be used for the supply and/or administration of P and GSL medicines helps ensure correct legal mechanisms in practice.
National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Events

Our forthcoming conferences and webinars covering a range of Medicines Optimisation issues with SPS and other great speakers and presenters.
Search our library of past events for recordings, presentations, and interviews with speakers, all to inform your practice.

Primary care

Our primary care resources and tools are for all those working in the area, including GPs, practice pharmacists and community pharmacy teams.

If you're a healthcare professional who needs further advice, get in touch with us. You can contact us through our single email or telephone number below. Please don't share patient identifiable data with us by email.
All our advice on using medicines safely and effectively in patients with swallowing difficulties.
All our training and guidance to help decision making about the use of medicines in breastfeeding.
All our training and guidance to help decision making about the use of medicines in pregnancy.
All vaccinations, including live vaccines, can be given during breastfeeding. The only exception is yellow fever vaccine which is not recommended.
Continue breastfeeding during COVID-19 infection, even if dexamethasone, Paxlovid, sotrovimab or tocilzumab are required. COVID-19 vaccines can also be given.
An overview of the Comirnaty 3 (THREE) (XBB.1.5) concentrate vaccine and signposts to other useful resources.
An example SOP for preparing Comirnaty 3 (THREE) (XBB.1.5) concentrate vaccine.
An overview of the Spikevax (XBB.1.5) vaccine and signposts to other useful resources.
An example SOP for preparing Spikevax (XBB.1.5) vaccine.
An example SOP for preparing Comirnaty 10 (XBB.1.5) ready to use vaccine.
An overview of the Comirnaty 10 (XBB.1.5) ready to use vaccine and signposts to other useful resources.
Continue breastfeeding during COVID-19 infection, even if dexamethasone, Paxlovid, sotrovimab or tocilzumab are required. COVID-19 vaccines can also be given.
Support for prescribing decisions in people on interacting medicines, those with swallowing difficulties, renal impairment, or who are pregnant or breastfeeding
We have information on COVID-19 vaccines as well as associated clinical information to support patient care.
Differing models exist for the supply and administration of COVID-19 treatments. We guide through the risks and mitigations associated with each.
Deployment should address a range of factors and be implemented through different mechanisms. Collecting data and learning will support continued safe use.
An outline process and supporting materials to help Trusts deploy sotrovimab
Guidance for Chief Pharmacists and supporting documents to achieve Institutional Readiness and deployment of COVID-19 Treatments
Medication Safety Across the System (MSATS) provides resources and networking to inspire and equip individuals in promoting the safe use of medicines.
Practical guidance on effective collaboration opportunities to promote medication safety improvements
Effective communication allows for timely responses to new and emerging medication risks and the sharing of potential safety solutions.
Healthcare professionals responsible for medication safety in their organisation must deliver an appropriate response to safety alerts
High quality reporting and management of incidents and harms ensures opportunities for learning and improving medication safety
Practical guidance to ensure opportunities to learn from local intelligence, including patient harm are translated into shared local and national learning
Healthcare professionals delivering the medication safety agenda in their organisation require an understanding of national policy, frameworks and legislation
Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety
Increased medication incident reporting provides greater opportunities for learning and improving medication safety
Practical guidance to support those undertaking medication incident investigations

Planning

Regularly updated material to support the introduction of adalimumab, eculizumab, natalizumab, ranibizumab and tocilizumab biosimilars.
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.

Tools

Summarised recommendations and guidance for medicines requiring monitoring to save you time when you're making monitoring decisions with patients
Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and CMU.
Information on stability for tablets and capsules to help create MCAs for patients. Find entries and then build and print lists specific to your MCA.
Advice on whether refrigerated medicines can or can’t be used after exposure to out-of-range temperatures. Find entries and build and print lists.